Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 30;13(11):3236. doi: 10.3390/jcm13113236

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Summary figure showing the major efficacy and safety outcomes with anticoagulation in patients having sub-clinical atrial fibrillation with stroke risk factor(s) in the NOAH-AFNET 6 trial, ARTESIA trial, and their study-level meta-analysis. NOAH-AFNET 6—Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial High-Rate Episodes Trial [15], ARTESIA—Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Subclinical Atrial Fibrillation Trial [16], DOAC—direct oral anticoagulant. Dark blue arrow indicates the direction of effect.